T cell receptors and immunoregulation'
Introduction Despite intensive research effort since 1970, it is only in the past two years that the receptor for antigen on T lymphocytes (Tr) has been characterized. The reasons for this earlier failure, as discussed by Dr A F Williams, were both conceptual and technological. In the former category was the implicit assumption by most immunologists that the Tr had to make use of the same genes as those involved in antigen recognition by B lymphocytes, i.e. immunoglobulin genes, minimally the variable, antigen-binding, regions. The fundamental observation by Zinkernagel & Doherty (1974) , that T cells recognize antigen in the context of major histocompatibility complex (MHC) encoded molecules, revealed much of the biological character of the Tr but compounded the difficulties of isolating it. Three major technological innovations were required: the establishment of cloned lines or hybridomas of T cells possessing a single defined specificity for antigen plus MHC product, the production of monoclonal antibodies to the clonotypic antigen-specific molecules on these clones or tumour lines, and the development of complementary DNA probes to examine the genome directly. Employing the first two of these methods, Haskins et al. (1983) and Meuer et al. (1983) showed that monoclonal antibodies to a mouse T hybridoma and human T cell clone, respectively, precipitated a two-chain structu-,t of about 90 kD molecular weight. This heterodimer comprised an acidic a-chain and basic fl-chain with similar characteristics to a molecule previously isolated using polyclonal, rabbit antibodies by Allison et al. (1982) from a murine lymphoma. Although there are variations in molecular size and charge between a-and fl-chains from differing species and clones, the 90 kD heterodimer is now declared to be the 'classical' receptor for antigen on T cells.
Supergenefamily
The amino acid composition of the Tr has been analysed either by proteolytic digestion and peptide mapping (fingerprinting) or by recombinant DNA techniques, the latter pioneered by Hedrick et al. (1984) and Yanagi et al. (1984) to first identify the Trfl genes of mouse and man respectively, and later the T,a genes (Chien et al. 1984 , Saito et al. 1984 . This genetic approach has yielded a great deal of information concerning the organization of the Tr genes, the current under-'Report of meeting of the Section of Clinical Immunology, 13 May 1985. Accepted 12 September 1985 0141-0768/85/121056-07/$02.00/0 standing of which was discussed by Dr L Hood.
The T, genes belong to what has been termed the immunoglobulin supergene family, encompassing a group of molecules with diverse functions and differing degrees of polymorphism, related by being composed of typical, immunoglobulin-like domains (Hood et al. 1985) . Members of this supergene family include the non-polymorphic polyimmhiToglobulin receptor on gut epithelium, Thy 1, Lyt 2 and L3T4 differentiation antigens of murine T lymphocytes and fl2-microglobulin.
Polymorphic members include class I and class II major histocompatibility molecules and the immunoglobulins. The Tr genes are clearly distinct from those of immunoglobulins, but share sequence homology and organization in having constant (C), variable (V), joining (J) and diversity (D) segments. The mouse Trfl locus on chromosome 6 possesses 2 virtually identical constant region genes, Cfll and C,B2; both have associated Jfl and Dfl segments and either may be transcribed in the functional Tr molecule. By contrast, there is a single Ca gene, no identified Da sequences, and a multitude of Ja genes within the mouse Tra gene complex on chromosome 14.
T, genes infunctionally distinct populations Unlike B lymphocytes, T cells are functionally heterogeneous. Some T cells regulate immune responses (e.g. T helper, Th; T suppressor, TJ) and tend to recognize antigen in the context of class II histocompatibility molecules, whereas others mediate effector functions and are restricted by class I products (e.g. T cytotoxic, T,) though the correlation is not absolute. Such functional differences were expected to be reflected in the use of separate V or C gene families, but analysis of a large number of T cell clones of differing function or restriction specificity has failed to confirm this supposition: similar V regions may be used by helper or cytotoxic T cells with unrelated antigen specificity (Rupp et al. 1985) . The only exception uniquely. The function of the Try products is, as yet, unknown.
By comparing identified Va and Vfl sequences from different T cell clones, estimates can be made of the relative size of the gene pool. Dr Hood calculated that the Vfl gene pool may be small, of the order of 20 or so different sequences, based on the occurrence of 10 identical Vfl sequences in the 19 presently described. By contrast, only 3 of 15 Va genes so far sequenced are the same, suggesting upwards of 50 Va sequences in the gene pool. There is likely to be a great deal of additional diversity within the Ja gene pool, too, for 18 separate Ja sequences have been identified and there could be a further 40 or more. This would compensate for the apparent lack of Da genes and somatic mutation within Tr genes.
Tr genes in lymphomas and leukaemias
The possibility that distinct Vfl genes might be associated with T cell malignancies was also discussed by Dr Hood. A monoclonal antibody raised to a peptide sequenced from the Vfl gene of a human T cell line reacted with 7 of 10 other T cell tumour lines tested. Moreover, the antibody blocked binding of the T cell leukemia virus, HTLV-1. The suggestion was that the expression of particular Vfl products might predispose to neoplastic transformation by acting as receptors for oncogenic viruses. Dr Tunnacliffe and his colleagues have examined cells from patients with T cell leukaemias or lymphomas, using a Cfl gene probe and restriction enzyme analysis, in order to demonstrate or confirm their T cell and clonal origin and determine whether there are rearrangements common to conditions such as acute lymphoblastic leukaemia, chronic lymphocytic leukaemia, Sezary's syndrome and adult T cell leukaemia. In all of 30 different samples, at least one Cfl gene rearrangement had occurred, but Dr Tunnacliffe had no direct evidence of common Vfl rearrangement patterns. Dr Tunnacliffe also described inversions of parts of chromosome 14, possibly involving the T,a locus and a cellular oncogene, and translocations between chromosomes 7 and 14, perhaps involving a and y or a6 and a loci, which may be the T cell counterparts of the rearrangements around immunoglobulin loci which contribute to B cell malignancies.
Expression of T, during T cell ontogeny
Control of the expression of the Tr during human T lymphocyte ontogeny was considered by Dr M J Owen and Dr E L Reinherz. The monoclonal antibodies OKT3, Leu 4 and UCHTI bind to a complex molecule (T3 or CD3) composed of three protein subunits, which is intimately associated with Tr and identifies mature human thymic and peripheral blood T cells. A murine equivalent of T3 has also been demonstrated recently (Van den Elsen et al. 1984) . Dr Owen and his colleagues have shown that human thymocytes, phenotypically negative for T3, contain mRNA transcripts for fi but not a chains (Collins et al. 1985) . These transcripts were either 1.3 kilobase (kb) or 1.1 kb in length, representing the entire rearranged V-D-J-C sequences or aberrant transcripts lacking Vfl, respectively. Similar data were obtained by Dr Reinherz who found, additionally, evidence of fi gene rearrangement in T3-negative thymocytes expressing the T6 antigen (about 80% of the total population). The most immature thymocytes (T6 negative) had not rearranged the Trfl genes.
Dr Owen had also investigated transcription of a and fi genes in a number of tumour lines arrested at various stages of T cell differentiation. As for thymocytes, Tr was only found on T3-positive lines and af chain transcription preceded that of a chain. Because transcription of one subunit of the T3 molecule had been found early in thymocyte ontogeny, it was concluded that Tra gene transcription controls the expression of the T3-T, complex, possibly as the limiting step in dimerization (Collins et al. 1985 ). An exception to this rule was uncovered in one line, HUT 78. Using a rabbit antiserum to the Tr, a 90 kD molecule was precipitated from the tumour cells which, on reduction, was found to be a fl-chain dimer. This novel molecule was complexed with T3, implying that the a chain is not always necessary for T3-Tr association or, indeed, expression. Whether this fl-fl dimer represents the receptor found on a small proportion of normal T lymphocytes, or a malignant or loss variant, remains to be elucidated.
Tcell activation through T3-T,complex
The activation of T cells following recognition of antigen and major histocompatibility molecules is dependent on a transmembrane signal which probably acts through the T3 complex. The Tr is non-covalently associated with a 20 kD glycosylated protein (3) and two other proteins, one of molecular weight 25 kD (a) and another of 20 kD (e), Borst et al. 1984) . Some antibodies to these monomorphic molecules can induce proliferation independently of Tr, as can antibodies to certain epitopes on the Tr molecule itself. Thus, there seem to be distinct sites on the T3-Tr complex which are critical for T cell activation. Alternatively, anti-T3 antibodies can block the response to antigen. Interpretation of such inhibition, however, as pointed out by Dr P C L Beverley, may be complicated by Fc dependent mechanisms. UCHT1, an anti-T3 monoclonal of IgGI subclass, is mitogenic but highly dependent on the presence of accessory cells, presumed to be macrophages.
This dependence probably results from a requirement for the production of interleukin I (IL-1) but replacement of accessory cells by IL-I has not been uniformly successful. A proportion of individuals (20-40%) fail to proliferate to soluble UCHTI, a failure which can be overcome by providing accessory cells from a responder or by coupling antibody to sepharose beads. Although antibodycoated beads reduce the requirement for accessory cells in all individuals, they cannot activate T cells if accessory cells are completely removed. It appears, therefore, that cross-linking is an essential element in activation via the T3-Tr complex, but that another signal, possibly IL-1, also is required for proliferation.
To study the effects of anti-T3 antibody on T cells in the absence of accessory cells, Dr Beverley and his colleagues have measured the mobilization of intracellular free Ca2 + ions fluorometrically by means of the dye, Quin 2. The data showed that responders and non-responders behaved similarly in that equivalent increases in free Ca2+ concentration were elicited by various anti-T3 antibodies (UCHT 1, Leu 4 and WT 32), confirming that there is no abnormality in the T cell triggering of non-responder individuals and indicating that Ca2 + mobilization is insufficient to induce proliferation. T tumour cells were also triggered by monoclonal anti-idiotypic antibodies to the Tr, yet Ca2 + mobilization could be enhanced by addition of anti-T3. The reason for this was unclear, but it could be that signals transmitted from Tr via T3 are less efficient than via T3 directly. An alternative pathway of T cell activation A second activation pathway which is independent of interaction with antigen/MHC product involves the receptor for sheep erythrocytes. The physiological role of this 50 kD glycoprotein, identified by OKT1 1 and Leu 5 monoclonal antibodies and designated T II (or CD2) has, so far, remained an enigma. Dr Reinherz and his group have defined 3 epitopes on T 11 with monoclonal antibodies and used these to explore their function. Antibodies to the T 112 determinant cause a conformational change which exposes the T 1H3 epitope. In concert, antibodies to T12 and T 113 cause T cell proliferation independent of IL-1 and induce expression of receptors for IL-2 on both thymocytes and peripheral T cells. Though T 11 and the T3-Tr complex are not linked physically in the plasma membrane, they are linked functionally, for pretreatment of T cells with a soluble, blocking anti-T3 antibody inhibited anti-TI 1 induced mitogenesis. Using Quin 2 fluorescence, Dr Beverley found that antibodies to T 11 but not T3 blocked activation by the lectin phytohaemagglutinin (PHA), indicating that the latter triggered proliferation via T 1. The nature of the interaction between T3-Tr and T I has not been defined, but Dr Reinherz proposed a role for TI 1 in the expansion of thymocytes and the elimination of self reactive clones (Reinherz 1985) . According to this hypothesis, the thymus contains a natural ligand for T I which induces proliferation of thymocytes in the absence of IL-I and is maintained by IL-2 provided by thymic medullary cells. If the thymocytes also possess high affinity receptors for self antigens, there is simultaneous binding through both T I and T3-Tr, causing inhibition of growth and death of these autoreactive clones.
Dr Reinherz (Littman et al. 1985) . A mouse thymidine kinase deficient fibroblast (L cell) line was transfected with a mixture of high molecular weight DNA from T8-positive T leukaemia cells and a thymidinekinase-containing plasmid. The L cells were then cultured in hypoxanthine-aminopterin-thymidine (HAT) medium, to select for thymidine kinase-positive transformants, and screened for expression of T8. The latter was neatly accomplished by first incubating the L cells with OKT 8 antibody and then developing with anti-mouse immunoglobulin antibodies coupled to erythrocytes. The T8-positive colonies were picked out and cloned. To attempt to rapidly purify the T8 gene, the cotransformed L cell DNA was used to transfect a second batch of L cells, with a repeated HAT selection. Messenger RNA from the secondary T8-positive transfectants was employed to obtain the T8 gene by subtractive hybridization (Hedrick et al. 1984) . In brief, mRNA from normal (T8-negative) L cells was hybridized with a radioactive complementary DNA (cDNA) reverse-transcribed from the mRNA of the transformed line. The remaining labelled cDNA, unique to the T8-positive transformants, was used to probe a library of human DNA genes to isolate and then sequence the T8 gene. The T8 gene consisted of a single domain of about 113 amino acids with homology to the V region of kappa light chains and mouse Thy 1.1. The surface structure is a 76 kD dimer of the gene product; on reduction of the disulphide bonds, two identical 32 kD subunits are revealed. The T8 gene shows no evidence of somatic rearrangement in T cell lines.
A similar strategy has been applied to isolate the T4 gene but only one primary transformant was established and no secondary transformants, presumably because of the larger size of the T4 gene (approximately 33 kb). The DNA so far sequenced codes for a 55 kD protein with similar characteristics to the 62 kD protein on the cell surface. The first 100 amino acids show striking homology to the V/I of the Tr. Indeed, this homology is greater than to T8. A J-like segment has been identified and the transmembrane region shown to have about 50% homology with class II genes. However, the remaining sequence does not match well with any other known proteins. Investigation of the interaction between T8 and T4 and class I and class II histocompatibility molecules, respectively, should be greatly facilitated by these gene sequence data. Dr Chess and his colleagues are presently applying similar molecular-cloning strategies to the Tl 1 and Tl surface antigens. HLA class II gene products Various aspects of the genetics of the HLA-D region, which encodes human class II MHC products, were discussed by Dr J Trowsdale. The nomenclature of the HLA-D genes has lately been revised, and the most likely order of subregions is now DP (formerly SB), DQ (formerly DC) and DR (see Bach 1985) . Class II molecules comprise a non-covalently associated 34 kD a and 28-29 kD /I chain. At the present time it is known that the DP subregion contains at least one functional and non-functional (pseudogene) pair of a and ,6 genes.
The DQ subregion, lying between DP and DR on chromosome 6, is similar to DP in having an expressed and pseudogene pair, but there may be no further loci. The non-expressed a and ,B genes of DQ (termed DXa and DX/I) are almost identical to the functional genes. The DR subregion contains a single a locus and 1-3 / loci, the precise number varying between different chromosomes, one of which is a pseudogene. The DRa-chain may combine with DR/B from either locus or either chromosome in a heterozygote, but probably does not associate with DP or DQ fi chains. Another class II locus, DO or DZ, has been described.
The most distinctive feature of class II (and class I) histocompatibility molecules is their polymorphism. All HLA-D subregions are polymorphic for/ chains, DR being the most and DP the least, polymorphic. By contrast, only DQ shows extensive a gene polymorphism, confined to the N-terminal al domain; DP displays limited polymorphism and DR none. It is significant that polymorphisms defined by restriction enzyme digestion show a complete correlation, to date, with serologically recognized alleles. Attempts have been made to analyse the function of various class II products by transfection of cosmid-cloned genes. L cells transfected with DP a and /I genes express the products, albeit at lower levels than B lymphocytes, and can present influenza neuraminidase peptides to specific T cell clones.
Expression of HLA class II molecules and autoimmunity
Many autoimmune diseases are in linkage disequilibrium with HLA-D alleles. Bottazzo et al. (1983) have proposed that the expression of class II histocompatibility molecules on the surface of cells which do not normally express them may be critical in the pathogenesis of autoimmune diseases, in particular thyroid-specific disorders. Three necessary criteria of this hypothesis, as applied to the thyroid, are that T cell products should induce abnormal class II expression on thyrocytes, that the cells should be able to present antigens to T lymphocytes, and that cells reactive to them should be found in the thyroid. Evidence supporting each of these criteria was reviewed by Professor M Feldmann.
Culture of thyroid cells with y-interferon (but not a-or /Iinterferon, or pure, recombinant IL-2) induced the expression of class II histocompatibility molecules. Of special interest was the observed synergy between y-interferon and other ligands, particularly thyroid-stimulating hormone; this synergy could be important for other tissues which do not respond to y-interferon alone (e.g. pancreatic islet cells). To investigate antigen presentation by thyrocytes, an influenza virus-specific T cell clone, reactive with a defined peptide of the haemagglutinin and restricted to DQ, was cultured with either peripheral blood or thyroid cells. The latter were obtained from collagenase digestion of thyroid tissue. Thyrocytes presented the peptide, but not live or fixed virus, demonstrating that such presentation was not a result of contamination of thyroid cell preparations with blood cells (which could present live or fixed virus) and that thyrocytes did not process antigen (Londei et al. 1984) . Presentation was specific and inhibited by anti-class II antibodies. The third criterion of the hypothesis was tested by isolating cells from thyroid tissue of patients with thyrotoxicosis (Graves' disease). Activated T cells were initially selected by culturing in IL-2 and subsequently cloned. Three patterns of reactivity emerged. The majority of clones (c. 70%) proliferated in IL-2 but failed to respond to autologous blood mononuclear cells or thyrocytes. Twenty percent reacted with autologous thyroid and blood cells. The remainder (c. 10%) were specific for thyroid autoantigens, proliferating only in response to thyroid cells, and releasing IL-2 and y-interferon All clones were T4-positive and HLA-D restricted (Londei et al. 1985) The elegant experimental validation of three criteria of their hypothesis has thus provided strong support for a role for abnormal class II antigen expression in thyroid autoimmunity which may be applicable to a variety of other organspecific autoimmune diseases.
Regulation ofspecific human antibody responses
Dr R E Ballieux and his coworkers have established an in vitro model for studying the regulation of specific human antibody responses. T lymphocyte-dependent responses to the hapten trinitrophenol (TNP) have been measured in a plaque assay, using various soluble or particulate antigens (e.g. ovalbumin, sheep erythrocytes) as carriers. Although the plaques are IgM and produced by cells with the characteristics of conventional activated B lymphocytes, they are extremely small. Dr Ballieux has found that the T cell requirement for help can be substituted by factors. Factors which augment B cell responses both specifically and nonspecifically are elicited when T lymphocytes are cultured with the carrier protein and monocytes. The specific factors can be absorbed and eluted from antigen coupled sepharose columns and act on B cells in the presence of monocytes. For T cells to produce the specific factor the monocytes need to be HLA-D compatible; however, allogeneic helper factors will function if added to monocytes, providing the latter are syngeneic with the B cells. If T cells are cultured with antigen in the absence of monocytes, specific suppressor factors are elaborated which also can be eluted from antigen coupled columns (Ballieux et al. 1979 ). These do not act by blocking helper factors, but act directly on the helper cells for antibody production. By definition, the cell producing suppressor factors is a suppressor effector cell; another cell, the suppressor inducer, is required for the induction of suppression. Dr Ballieux and his colleagues found that T cel-ls bearing a receptor for IgM antibodies (Tp cells), if mixed with semi-purified B cells and monocytes, would enhance antibody production, indicating that the population contained helper cells. Yet if unseparated blood lymphocytes were used as the source of B cells, T,u cells failed to augment the response. They concluded that Tpu cells, which were also T4-positive, contained both suppressor inducer and helper cells. A third, intermediate, cell type has also been implicated in the full development of suppression -the amplifier cellwhich, like the effector of suppression, is T8-positive. Suppressor factors inhibit not only helper but also suppressor inducer cells, indicative of a possible negative feedback pathway Ballieux & Heijnen 1983) . Suppression in general was activated by relatively high doses of antigen.
The culture system has been applied to B cell responses to thyroglobulin in normal subjects and individuals with autoimmune disease of the thyroid. Soluble thyroglobulin failed to elicit plaque formation; however, blood cells from patients responded when the autoantigen was coupled to agarose beads. These plaques were large and could be quantitated by an enzymelinked immunosorbent assay (a 'spot' ELISA). Fourteen of 19 patients examined produced IgG, and not IgM, plaques even though their sera contained IgM and IgA autoantibodies. Blood cells from normal subjects did not respond but spleen cells from 2 individuals produced IgM, and not IgG, plaque responses. There may be abnormalities in T helper and suppressor circuits in thyroid autoimmunity, in non-organ-specific autoimmune disease and other, diverse hereditary disorders such as neutropenia and haemophilia, but the evidence is, so far, preliminary.
Murine helper and suppressorfactors
Antigen-specific suppressor and helper factors were considered by Dr G L Asherson, with reference to the well known model of contact sensitivity to picryl (TNP) chloride in the mouse. Contact sensitivity can be induced by painting the skin with picryl chloride or by injecting picrylated spleen cells into the footpads. If the dose is too low there is no sensitization, but suboptimal doses can be rendered immunogenic if the cells are preincubated in antigen-specific T helper factor(s). These are contained in supernatants prepared from regional lymph node T cells, four days after immunization by skin painting with picryl chloride. The helper factor has a molecular weight of about 60 kD and a minimal structure of two disulphide-bonded chains. One chain binds to antigen in the absence of MHC-encoded determinants, the other chain carries determinants encoded by the I-A subregion. These class II epitopes are recognized by a structure on the antigenbinding chain, resulting in a genetic restriction in their interaction. A further genetic restriction is that the host and factor must match at I-A, though the genotype of the picryl-modified cell used as a source of antigen is unimportant (e.g. H-2d picrylated cells plus H-2" derived helper factor lead to contact sensitivity in H-2k mice). If the disulphide bonds are reduced and then alkylated to prevent recombination, the two chains can be separated by affinity chromatography on antigen. Non-antigen binding chains from mice primed to oxazolone, a non-crossreactive hapten, can complement the antigen-binding chain of the picrylspecific factor. In contrast to most antibody, this suggests that the second chain makes little or no contribution to the antigen-binding site. Dr Asherson proposed that the helper factor acted by increasing the amount of I-A encoded determinants in proximity to the antigen.
Antigen-specific suppressor factor(s), obtained from the supernatants of lymphoid cells after intravenous injection of picrylsulphonic acid, or picrylated cells, and skin painting, are assayed for their capacity to suppress the adoptive transfer of contact sensitivity by immune lymphoid cells. The suppressor factor has a two-chain structure, analogous to helper factor, with the I-A restriction being replaced by epitopes encoded by the I-J subregion. If the final painting with picryl chloride is omitted, the antigen-binding chain alone is secreted. Although the suppressor factor(s) are specific, they act via an acceptor cell which produces nonspecific suppression. This cell binds the antigen-specific T suppressor factor and is triggered by antigen associated with an I-J controlled product, which is distinct from that involved in interchain complementation. The T acceptor cell, which is sensitive to adult thymectomy and cyclophosphamide, is only found in primed mice, though the specificity of the priming agent is not important. The nonspecific inhibitor released from T acceptor cells is about 50 kD and blocks both contact sensitivity and IL-2 production. Macrophages can also act as acceptor cells but release a 10-20 kD nonspecific factor. Dr Asherson suggested that the effect of suppressor factors on IL-2 production may be one of the features determining the balance between immunity and tolerance, a view supported by the finding that sensitization, rather than suppression, was induced when IL-2 was given in conjunction with picrylated cells intravenously.
Human T8-T4 cell interactions The last speaker to consider the regulation of antigen-specific immune response was Professor T Lehner. B cell responses to the hapten dinitrophenol (DNP) have been investigated using a 185 kD protein antigen isolated from Streptococcus mutans (SA I/II) as a T dependent carrier. Employing a xenogeneic plaque assay as the indicator system, in which supernatants derived from human T cell cultures are assayed on mouse B lymphocytes, help and suppression have been simultaneously analysed. Helper function is assayed by incubation of supernatants (factors) with unprimed B cells. Suppressor function is assayed by culture with unprimed B cells and carrier primed (mouse) T lymphocytes. Doseresponse studies showed that human T cells (from HLA-DRw6 negative individuals) produced suppressor factors when cultured with relatively low (1 ng per/5 x 106 cells) or high doses (1O jg) of SA 1/11 and failed to provide help, whereas an intermediate dose (1000 ng) helped and did not suppress (Lehner 1982) . However, when the T cells were fractionated into T4-enriched and T8enriched populations, both help and suppression, respectively, were uncovered at all doses tested, implying that suppression -dominant at low and high doses-was being overridden at 10OOng, perhaps by an opposing, contrasuppressor cell mechanism.
Because in mouse models cells involved in contrasuppression have been found to bind to a lectin isolated from Vicia villosa (VV), Lehner et al. (1985) panned T8-enriched cells onto lectin-coated plates and found that these cells were also enriched for cells that bound 125I-labelled SA I/II directly (Lehner 1983) . Functionally the T8-positive W adherent cells bound SA directly and induced T4-enriched lymphocytes to provide help in the absence of monocytes. VV non-adherent T8 cells did not present antigen but were enriched for suppressor cells, as evidenced by their capacity to inhibit the helper activity of mixtures of monocytes and T4 cells. If W adherent T8 cells were used in place of monocytes, the cultures induced help rather than suppression. The results indicated that T8 VV adherent cells were contrasuppressive, a function probably related to their capacity to bind and present antigen. Comparable data were obtained using cells panned on SA I/II coated plates. Because the xenogeneic assay is open to potential criticism, a radioimmunoassay has been developed to quantitate antibody production by human B cells. The results have confirmed those from the plaque assay.
An intriguing observation has been that monoclonal antibodies to mouse I-J encoded molecules bind to about one quarter of T8-positive lymphocytes and block antigen presentation and contrasuppression by W adherent T8 cells (Lehner et al. 1984 ). Antibodies to human class II molecules are similarly inhibiting. Whether these I-J like molecules are analogous to their murine counterpart is unknown. It is possible that they act to focus antigen for recognition by the T4-positive helper cells.
Despite the enormous progress being made concerning the nature of T cell receptors, a number of fundamental questions remain unanswered. For example, are the antigen-recognition products on T cell factors similar to the V region products used for the Tr? The finding that factors bind to nominal antigen alone whilst the functional cells, at least for Th and Tc, recognize neither antigen nor histocompatibility molecules in isolation seems to argue against this. It may be that factors make use of different V region sequences of the Tr genes. The question of what genes form the basis of specificity for Ts or contrasuppressor cells is unresolved, as are which parts of the Tra or fi chains bind to antigen or MHC product. New 
